Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Key Highlights
- ➤Q3 fiscal 2026 results scheduled for release before markets open November 5
- ➤Management conference call set for 8:00 a.m. Eastern Time November 5
- ➤Apyx Medical markets Renuvion, AYON, and J-Plasma surgical systems
CLEARWATER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion(®) and the AYON Body Contouring System™ (AYON), today announced that its financial results for the third quarter of fiscal year 2026 will be released before markets open on Thursday, November 5(th).
Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, November 5(th), to discuss the results of the quarter, followed by a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 20167. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will also be archived for future reference.
Get started
Create a free account to read the full story.